درباره این راهنما

این راهنما بر اساس پژوهش‌های همتاداوری‌شده از APA، DSM-5-TR، ICD-11، NICE، IOCDF، Lancet، JAMA و Cochrane تهیه شده است. تمام منابع در زبان انگلیسی در پایان صفحه فهرست شده‌اند تا قابل ارجاع علمی باشند. این محتوا جایگزین مشاوره حضوری با درمانگر متخصص نیست.

⚠ در صورت بحران

اگر افکار آسیب به خود یا دیگران دارید: ۹۸۸ (آمریکا/کانادا) یا اورژانس محلی. خط کمک به کودکان کانادا: ۱-۸۰۰-۶۶۸-۶۸۶۸. افکار مزاحم در OCD اغلب «خودناهم‌خوان» (ego-dystonic) هستند و نشانه قصد آسیب نیستند، اما اگر در شک هستید حتماً با متخصص تماس بگیرید.

بخش ۱: شناخت OCD

بخش ۲: علائم، انواع و Pure O

بخش ۳: تشخیص و ارزیابی

بخش ۴: درمان (ERP، CBT، دارو)

بخش ۵: زندگی با OCD

References (English, peer-reviewed)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). DSM-5-TR; 2022.
2. World Health Organization. ICD-11 for Mortality and Morbidity Statistics: 6B20 Obsessive-compulsive disorder. WHO; 2024.
3. Stein DJ, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5(1):52.
4. Rachman S. A cognitive theory of obsessions. Behav Res Ther. 1997;35(9):793-802.
5. Salkovskis PM. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther. 1985;23(5):571-583.
6. Mataix-Cols D, et al. A multidimensional model of OCD. Am J Psychiatry. 2005;162(2):228-238.
7. Bloch MH, et al. Meta-analysis of the symptom structure of OCD. Am J Psychiatry. 2008;165(12):1532-1542.
8. McKay D, et al. The structure of obsessive-compulsive symptoms. Clin Psychol Rev. 2004;24(3):283-313.
9. Pauls DL, et al. OCD: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410-424.
10. Saxena S, et al. Neuroimaging and frontal-subcortical circuitry in OCD. Br J Psychiatry. 1998;173(S35):26-37.
11. Pittenger C, et al. Glutamate dysfunction in OCD. Pharmacol Ther. 2011;132(3):314-332.
12. Milad MR, Rauch SL. OCD: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16(1):43-51.
13. Menzies L, et al. Integrating evidence from neuroimaging and neuropsychological studies of OCD. Neurosci Biobehav Rev. 2008;32(3):525-549.
14. Robbins TW, et al. Obsessive-compulsive disorder: puzzles and prospects. Neuron. 2019;102(1):27-47.
15. Ruscio AM, et al. The epidemiology of OCD in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
16. Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the NCS-R. Arch Gen Psychiatry. 2005;62(6):593-602.
17. Fawcett EJ, et al. Women are at greater risk of OCD than men: a meta-analytic review. J Clin Psychiatry. 2020;81(4):19r13085.
18. Stein DJ. Obsessive-compulsive disorder. Lancet. 2002;360(9330):397-405.
19. Mataix-Cols D, et al. Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety. 2010;27(6):556-572.
20. Pinto A, et al. OCD versus OCPD: a comparative analysis. J Anxiety Disord. 2014;28(8):907-913.
21. Eisen JL, et al. The relationship between OCD and OCPD. Compr Psychiatry. 2006;47(4):294-301.
22. Swedo SE, et al. PANDAS: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264-271.
23. Chang K, et al. Clinical evaluation of youth with PANS: recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 2015;25(1):3-13.
24. Murphy TK, et al. Cefdinir for recent-onset pediatric neuropsychiatric disorders. J Child Adolesc Psychopharmacol. 2017;27(7):659-664.
25. Mataix-Cols D, et al. Population-based, multigenerational family clustering study of OCD. JAMA Psychiatry. 2013;70(7):709-717.
26. Browne HA, et al. Genetics of OCD and related traits. Annu Rev Clin Psychol. 2014;10:275-297.
27. van Grootheest DS, et al. Twin studies on OCD: a review. Twin Res Hum Genet. 2005;8(5):450-458.
28. Williams MT, et al. Myth of the pure obsessional type in OCD. Depress Anxiety. 2011;28(6):495-500.
29. Sibrava NJ, et al. Mental rituals in OCD. J Anxiety Disord. 2011;25(7):972-979.
30. Clark DA, Inozu M. Unwanted intrusive thoughts: cultural, contextual, covariational, and characterological determinants of diversity. J Obsessive Compuls Relat Disord. 2014;3(2):195-204.
31. Booth BD, Friedman SH. Obsessions of child murder: underrecognized symptoms of OCD. J Am Acad Psychiatry Law. 2014;42(1):66-74.
32. Cougle JR, et al. Quality of life in OCD: the role of mental contamination concerns. Behav Res Ther. 2008;46(9):1099-1106.
33. Williams MT, Farris SG. Sexual orientation OCD: clinical characteristics and treatment. J Cogn Psychother. 2011;25(2):89-104.
34. Glazier K, et al. Stigma and shame as barriers to treatment for OCD. J Obsessive Compuls Relat Disord. 2015;4:13-19.
35. Bruce SL, et al. POCD: clinical characteristics, comorbidity, and treatment. J Cogn Psychother. 2018;32(4):304-319.
36. Glazier K, et al. Misdiagnosis of pedophilia OCD. J Obsessive Compuls Relat Disord. 2013;2(2):169-176.
37. Doron G, et al. Relationship-related obsessive-compulsive phenomena: the case of relationship-centred and partner-focused obsessive compulsive symptoms. Aust Clin Psychol. 2014;1(1):4-23.
38. Doron G, et al. ROCD: interference, symptoms, and maladaptive beliefs. Front Psychiatry. 2014;5:58.
39. Abramowitz JS, et al. Religious obsessions and compulsions in a non-clinical sample. Behav Res Ther. 2002;40(7):825-838.
40. Huppert JD, et al. Scrupulosity: a unique subtype of OCD. Curr Psychiatry Rep. 2007;9(4):282-289.

References (continued, 41–80)

41. Rachman S. Pollution of the mind. Behav Res Ther. 1994;32(3):311-314.
42. Cougle JR, Lee HJ. Pathological and non-pathological features of OCD: revisiting basic assumptions. J Obsessive Compuls Relat Disord. 2014;3(1):12-20.
43. Coles ME, et al. “Not just right experiences” and OCD. Behav Res Ther. 2003;41(6):681-700.
44. Leckman JF, et al. Symptom dimensions and subtypes of OCD: a developmental perspective. Dialogues Clin Neurosci. 2009;11(1):21-33.
45. Abramowitz JS, et al. Health anxiety and OCD: clinical correlates. J Anxiety Disord. 2014;28(8):812-818.
46. Newby JM, et al. Internet-delivered cognitive behavioural therapy for health anxiety. J Anxiety Disord. 2018;57:71-79.
47. de Silva P, Marks IM. Mental rituals in OCD. Behav Res Ther. 1999;37(11):1085-1090.
48. Williams MT, et al. Cognitive-behavioral therapy for OCD: covert rituals. J Cogn Psychother. 2011;25(2):109-122.
49. Goodman WK, et al. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Arch Gen Psychiatry. 1989;46(11):1006-1011.
50. Storch EA, et al. Florida Obsessive-Compulsive Inventory: development and psychometric properties. J Clin Psychol. 2007;63(9):851-859.
51. Foa EB, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002;14(4):485-496.
52. Rachman S, de Silva P. Abnormal and normal obsessions. Behav Res Ther. 1978;16(4):233-248.
53. Radomsky AS, et al. Part 1—You can run but you can’t hide: intrusive thoughts on six continents. J Obsessive Compuls Relat Disord. 2014;3(3):269-279.
54. Phillips KA, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety. 2010;27(6):528-555.
55. Frost RO, et al. The hoarding of possessions. Behav Res Ther. 1996;34(4):341-350.
56. García-Soriano G, et al. Diagnostic delay and OCD. J Affect Disord. 2014;163:124-132.
57. Glazier K, et al. High rates of OCD misdiagnosis by mental health professionals. Ann Clin Psychiatry. 2015;27(2):82-89.
58. Pinto A, et al. The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry. 2006;67(5):703-711.
59. Torres AR, et al. OCD and comorbidities: results from the Brazilian Research Consortium. CNS Spectr. 2013;18(6):298-305.
60. Murphy TK, et al. Tic disorders and OCD. Adv Neurol. 2006;99:39-54.
61. Cadman T, et al. Obsessive-compulsive disorder in adults with high-functioning autism spectrum disorder. J Autism Dev Disord. 2015;45(11):3559-3568.
62. Meier SM, et al. Obsessive-compulsive disorder and autism spectrum disorders: longitudinal and offspring risk. PLoS One. 2015;10(11):e0141703.
63. Angelakis I, et al. Suicidality in OCD: a systematic review and meta-analysis. Clin Psychol Rev. 2015;39:1-15.
64. Hollander E, et al. The cost and impact of compulsivity. CNS Spectr. 2016;21(1):51-59.
65. Marques L, et al. Barriers to treatment and service utilization in an internet sample of individuals with OCD. Depress Anxiety. 2010;27(5):470-475.
66. Kochanski-Ruscio KM, et al. OCD-related disability and quality of life. Compr Psychiatry. 2014;55(7):1645-1655.
67. Subramaniam M, et al. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013;27(5):367-383.
68. Foa EB, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in OCD. Am J Psychiatry. 2005;162(1):151-161.
69. Skapinakis P, et al. Pharmacological and psychotherapeutic interventions for management of OCD: systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730-739.
70. Koran LM, et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(7 Suppl):5-53.
71. Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986;99(1):20-35.
72. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry. 2006;51(7):407-416.
73. Olatunji BO, et al. Mediation of symptom changes during inpatient treatment for OCD. Behav Res Ther. 2013;51(8):494-501.
74. National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. NICE Clinical Guideline CG31; 2005, updated 2024.
75. American Psychological Association Division 12. Treatment: Exposure and Response Prevention for OCD. APA; 2024.
76. International OCD Foundation. Treatment of OCD: ERP. IOCDF Clinical Resources; 2024.
77. Foa EB, et al. Two-year follow-up of exposure and ritual prevention. J Clin Psychiatry. 2013;74(5):464-469.
78. Stewart SE, et al. Predictors of treatment response in pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2008;47(8):927-933.
79. O’Connor KP, Aardema F. Clinician’s Handbook for Obsessive Compulsive Disorder: Inference-Based Therapy. Wiley; 2012.
80. Aardema F, et al. Inference-based approach versus cognitive behavioral therapy in the treatment of OCD. Psychother Psychosom. 2017;86(2):112-114.

References (continued, 81–120)

81. Bloch MH, et al. Meta-analysis of the dose-response relationship of SSRI in OCD. Mol Psychiatry. 2010;15(8):850-855.
82. Soomro GM, et al. Selective serotonin re-uptake inhibitors versus placebo for OCD. Cochrane Database Syst Rev. 2008;(1):CD001765.
83. Pittenger C, Bloch MH. Pharmacological treatment of OCD. Psychiatr Clin North Am. 2014;37(3):375-391.
84. Issari Y, et al. Early onset of response with SSRIs in OCD. J Clin Psychiatry. 2016;77(5):e605-611.
85. Fineberg NA, et al. Pharmacotherapy of OCD: evidence-based treatment. Aust N Z J Psychiatry. 2013;47(2):121-141.
86. Twohig MP, et al. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for OCD. J Consult Clin Psychol. 2010;78(5):705-716.
87. Bluett EJ, et al. Acceptance and commitment therapy for anxiety and OCD spectrum disorders: a systematic review and meta-analysis. J Anxiety Disord. 2014;28(6):612-624.
88. Carmi L, et al. Efficacy and safety of deep transcranial magnetic stimulation for OCD: a multicenter, double-blind, randomized clinical trial. Am J Psychiatry. 2019;176(11):931-938.
89. Greenberg BD, et al. Three-year outcomes in deep brain stimulation for highly resistant OCD. Neuropsychopharmacology. 2006;31(11):2384-2393.
90. Rodriguez CI, et al. Randomized controlled crossover trial of ketamine in OCD. Neuropsychopharmacology. 2013;38(12):2475-2483.
91. Eisen JL, et al. Five-year course of OCD: predictors of remission and relapse. J Clin Psychiatry. 2013;74(3):233-239.
92. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1999;56(2):121-127.
93. Pallanti S, Quercioli L. Treatment-refractory OCD: methodological issues, operational definitions, and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):400-412.
94. Veale D, et al. Atypical antipsychotic augmentation in SSRI treatment refractory OCD. BMC Psychiatry. 2014;14:317.
95. Abramowitz JS, et al. Exposure Therapy for Anxiety: Principles and Practice. Guilford; 2019.
96. Foa EB, Yadin E, Lichner TK. Exposure and Response (Ritual) Prevention for OCD: Therapist Guide. Oxford; 2012.
97. Salkovskis PM, Westbrook D. Behaviour therapy and obsessional ruminations: can failure be turned into success? Behav Res Ther. 1989;27(2):149-160.
98. Wells A. Cognitive Therapy of Anxiety Disorders: A Practice Manual and Conceptual Guide. Wiley; 1997.
99. Salkovskis PM, et al. Reassurance seeking in OCD: a clinical analysis. Behav Res Ther. 2003;41(6):587-590.
100. Parrish CL, Radomsky AS. Why do people seek reassurance and check repeatedly? J Anxiety Disord. 2010;24(2):211-222.
101. Foa EB, et al. Randomized clinical trial of CBT and SSRI in pediatric OCD. JAMA. 2004;292(16):1969-1976.
102. Storch EA, et al. Randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in OCD. Am J Psychiatry. 2013;170(11):1310-1318.
103. Pediatric OCD Treatment Study (POTS) Team. CBT, sertraline, and their combination for children and adolescents with OCD. JAMA. 2004;292(16):1969-1976.
104. Geller DA, et al. Practice parameter for the assessment and treatment of children and adolescents with OCD. J Am Acad Child Adolesc Psychiatry. 2012;51(1):98-113.
105. Whittal ML, et al. Treatment of obsessive-compulsive disorder: cognitive behavior therapy versus exposure and response prevention. Behav Res Ther. 2005;43(12):1559-1576.
106. van Oppen P, et al. Cognitive therapy and exposure in vivo in the treatment of OCD. Behav Res Ther. 1995;33(4):379-390.
107. Twohig MP, et al. ACT for OCD: a randomized controlled trial. Behav Res Ther. 2018;108:1-9.
108. Hayes SC, et al. Acceptance and Commitment Therapy: The Process and Practice of Mindful Change. Guilford; 2012.
109. Walling SM, et al. Mindfulness-based cognitive therapy for OCD. J Cogn Psychother. 2016;30(3):192-208.
110. Külz AK, et al. Mindfulness-based cognitive therapy in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 2019;269(2):223-233.
111. Carmi L, et al. Long-term efficacy of deep TMS for OCD. J Psychiatr Res. 2018;101:75-82.
112. Trevizol AP, et al. TMS for OCD: an updated systematic review and meta-analysis. J ECT. 2016;32(4):262-266.
113. Denys D, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory OCD. Arch Gen Psychiatry. 2010;67(10):1061-1068.
114. Goodman WK, et al. Deep brain stimulation for intractable OCD: pilot study using a blinded, staggered-onset design. Biol Psychiatry. 2010;67(6):535-542.
115. Bloch MH, et al. Effects of ketamine in treatment-refractory OCD. Biol Psychiatry. 2012;72(11):964-970.
116. Sharma E, Math SB. Course and outcome of OCD. Indian J Psychiatry. 2019;61(Suppl 1):S43-S50.
117. Catapano F, et al. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors. J Psychiatr Res. 2006;40(6):502-510.
118. Reddy YC, et al. Long-term follow-up study of OCD: clinical features and remission. J Clin Psychiatry. 2003;64(7):824-830.
119. Steketee G, et al. Treatment for Hoarding Disorder: Workbook. Oxford; 2014.
120. Fineberg NA, et al. New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectr. 2014;19(1):69-89.

References (continued, 121–155)

121. Mancebo MC, et al. Long-term course of OCD: 10-year follow-up of the Brown Longitudinal Study. J Clin Psychiatry. 2020;81(6):20m13267.
122. Eisen JL, et al. Five-year course of OCD: predictors of remission and relapse. J Clin Psychiatry. 2013;74(3):233-239.
123. Simpson HB, et al. Patterns of remission and recurrence in OCD: a 2-year follow-up. J Clin Psychiatry. 2006;67(2):269-276.
124. Foa EB, et al. Six-month follow-up of randomized trial of exposure and ritual prevention plus medication. Am J Psychiatry. 2013;170(11):1294-1303.
125. Whittal ML, et al. Group and individual treatment of OCD using cognitive therapy and exposure plus response prevention: 2-year follow-up. J Consult Clin Psychol. 2008;76(6):1003-1014.
126. IOCDF. Family Guidelines for Living with OCD. International OCD Foundation; 2023.
127. Lebowitz ER, et al. SPACE: Supportive Parenting for Anxious Childhood Emotions—a parent-based treatment. J Am Acad Child Adolesc Psychiatry. 2020;59(3):362-372.
128. Thompson-Hollands J, et al. Family accommodation in pediatric OCD: associations with symptom severity and outcomes. J Clin Child Adolesc Psychol. 2014;43(5):785-795.
129. Storch EA, et al. Family accommodation in pediatric OCD. J Clin Child Adolesc Psychol. 2007;36(2):207-216.
130. Calvocoressi L, et al. Family accommodation in OCD: instrument development and assessment. J Nerv Ment Dis. 1999;187(10):636-642.
131. Russell AJ, et al. Cognitive-behavior therapy for comorbid OCD in high-functioning autism: an RCT. J Child Psychol Psychiatry. 2013;54(7):697-708.
132. Postlethwaite A, et al. Prevalence of suicidal thoughts and behaviours in OCD: meta-analysis. J Affect Disord. 2019;256:174-187.
133. Albert U, et al. Suicide risk in OCD and exploration of risk factors: systematic review. Curr Neuropharmacol. 2019;17(8):681-696.
134. Krzyszkowiak W, et al. Cognitive-behavioural therapy for OCD during pregnancy and postpartum. Psychiatr Pol. 2019;53(2):417-432.
135. Russell EJ, et al. Risk of perinatal OCD: meta-analysis. J Clin Psychiatry. 2013;74(4):377-385.
136. Brandes M, et al. Postpartum onset OCD: diagnosis and management. Arch Womens Ment Health. 2004;7(2):99-110.
137. McGuinness M, et al. The relationship between OCD and stress: cortisol and HPA axis dysregulation. Psychoneuroendocrinology. 2017;82:70-79.
138. Adams TG, et al. Stress, HPA axis, and OCD severity. Depress Anxiety. 2018;35(8):724-731.
139. Real E, et al. Stressful life events at onset of OCD: relevance to clinical phenotype. J Affect Disord. 2011;130(3):459-463.
140. Pinto A, et al. Theme shifting in OCD: clinical characteristics and treatment implications. J Anxiety Disord. 2008;22(8):1499-1505.
141. Williams MT, et al. Heterogeneity of OCD: subtypes and theme presentations. Curr Psychiatry Rep. 2013;15(11):396.
142. Mataix-Cols D, et al. Symptom dimensions in OCD: implications for assessment and treatment. J Clin Psychiatry. 2005;66(11):1379-1387.
143. Hezel DM, McNally RJ. A theoretical review of cognitive biases and deficits in OCD. Biol Psychol. 2016;121:221-232.
144. Wheaton MG, et al. Relapse prevention in OCD after ERP: predictors and strategies. Cogn Behav Ther. 2018;47(2):149-164.
145. Simpson HB, et al. Maintenance treatment in OCD: prevention of relapse. Br J Psychiatry. 2010;197(2):128-134.
146. Fineberg NA, et al. Pharmacotherapy of OCD: evidence-based treatment and beyond. Aust N Z J Psychiatry. 2013;47(2):121-141.
147. Kotapati VP, et al. Effectiveness of ERP combined with SSRIs in OCD: meta-analysis. Front Psychiatry. 2019;10:150.
148. McKay D, et al. Efficacy of cognitive-behavioral therapy for OCD: a meta-analysis. Clin Psychol Rev. 2015;40:156-169.
149. Hofmann SG, et al. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36(5):427-440.
150. Olatunji BO, et al. Cognitive-behavioral therapy for OCD: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013;47(1):33-41.
151. National Institute of Mental Health (NIMH). Obsessive-Compulsive Disorder. NIMH; 2023.
152. Mayo Clinic. Obsessive-Compulsive Disorder (OCD): Diagnosis and Treatment. Mayo Foundation; 2024.
153. Cleveland Clinic. Obsessive-Compulsive Disorder (OCD). Cleveland Clinic Health Library; 2024.
154. Anxiety and Depression Association of America (ADAA). OCD: Symptoms and Treatment. ADAA; 2024.
155. World Health Organization (WHO). ICD-11 for Mortality and Morbidity Statistics: 6B20 Obsessive-compulsive disorder. WHO; 2024.

آماده دریافت کمک برای OCD هستید؟

درمان مبتنی بر شواهد با ERP، I-CBT، ACT و حمایت نوروفیدبک. حضوری در کوکیتلام (ونکوور بزرگ) و آنلاین در سراسر بریتیش کلمبیا. خدمات به انگلیسی و فارسی.

صفحه اصلی همه پرسش‌های متداول

دکتر ساموئل — مشاور بالینی ثبت‌شده و متخصص نوروفیدبک